Actuate Therapeutics, Inc. (ACTU)

Actuate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	13.16	8.64	2.96	20.45
Cash & Short-Term Investments	13.16	8.64	2.96	20.45
Cash Growth	52.28%	192.08%	-85.53%	-
Other Current Assets	0.48	0.57	0.04	0.03
Total Current Assets	13.64	9.21	3	20.48
Other Long-Term Assets	0.39	0.11	-	-
Total Assets	14.04	9.32	3	20.48
Accounts Payable	1.52	1.92	3.42	2.13
Accrued Expenses	4.16	6.81	3.5	2.21
Other Current Liabilities	0.03	0.07	-	-
Total Current Liabilities	5.71	8.8	6.92	4.34
Other Long-Term Liabilities	0.4	0.41	1.52	1.31
Total Long-Term Liabilities	0.4	0.41	1.52	1.31
Total Liabilities	6.11	9.21	8.44	5.65
Common Stock	0	0	0	0
Additional Paid-in Capital	162.53	132.48	5.47	5.04
Retained Earnings	-154.61	-132.38	-105.1	-80.35
Total Common Shareholders' Equity	7.92	0.1	-99.63	-75.31
Minority Interest	-	-	94.18	90.14
Shareholders' Equity	7.92	0.1	-5.45	14.83
Total Liabilities & Equity	14.04	9.32	3	20.48
Net Cash (Debt)	13.16	8.64	2.96	20.45
Net Cash Growth	52.28%	192.08%	-85.53%	-
Net Cash Per Share	0.63	1.03	2.06	16.89
Book Value	7.92	0.1	-99.63	-75.31
Book Value Per Share	0.38	0.01	-69.43	-62.20
Tangible Book Value	7.92	0.1	-99.63	-75.31
Tangible Book Value Per Share	0.38	0.01	-69.43	-62.20

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q